MondayJan 24, 2022 12:53 pm

Flora Growth Corp. (NASDAQ: FLGC) Kicks off 2022 with Successful First Cannabis Extraction at new Colombia Facility, the Appointment of Tim Leslie as Advisory Board Chairman, and 360 Financial Inc.’s FLGC stock purchase

Flora Growth just announced the production of its first batch of crude oil through its newly constructed facility in Colombia The company has also initiated the EU-GMP certification process that will allow it to target international medical cannabis markets Flora Growth also announced the appointment of Tim Leslie as Chairman of its newly established Advisory Board Mr. Leslie will play a key role in advising the company on how best to navigate the regulatory framework of building a truly global company 360 Financial, Inc. announced the purchase of 13,162 Flora Growth shares as of Q4 2021 Flora Growth (NASDAQ: FLGC)…

Continue Reading

ThursdayJan 20, 2022 1:01 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Great Start to its 2022 R&D Programs Following Independent Review Board Approval

Lexaria received independent review board approval for its HYPER-H21-4 human clinical study for hypertension treatment The stage is also set for other R&D programs for the 2022 calendar year, including HOR-A22-1, DEM-A22-1, RHEUM-A22-1 and DIAB-A22-1 All of these 2022 R&D programs are fully funded, with Lexaria having raised approximately $15 million over the 2021 calendar year Lexaria believes that these programs will build significant value for its stakeholders and pursue policies for substantial improvements to human health In late 2021, Lexaria Bioscience (NASDAQ: LEXX) announced several new and ongoing R&D programs for its patented DehydraTECH(TM) technology. While making the announcement,…

Continue Reading

TuesdayJan 18, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) in 2021, Year in Review

RWB marked 2021 with strategic acquisitions, with the most notable of them being Acreage Holdings Inc. and a 45,000 square foot greenhouse in Apopka, Florida These strategic investments would see the company steadily grow its revenue, marking a 93% year-over-year growth by Q3 The year also marked notable appointments, including Ryan Costello and Colby De Zen, both into the company’s Board of Directors RWB is confident that the foundations laid down in 2021 will play a vital role in the company’s growth in 2022, as well as creating shareholder value Since its inception, Red White & Bloom Brands (CSE: RWB)…

Continue Reading

FridayJan 14, 2022 9:00 am

After a Successful 2021, Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off 2022 With New Media Strategy, Plans for Clinical Study Advancements

Lexaria has multiple studies planned that will commence early in 2022 DehydraTECH increases Lexaria’s ability to leverage multiple markets, including the growing CBD sector, which is expected to meet and exceed $108 billion in revenue by 2027 DehydraTECH can increase the efficacy of the drugs being administered, offering faster absorption and lowering the delivery time In a strategic move to start off 2022, Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, has announced that it has signed an advertising and media contract with financial technology company SRAX (NASDAQ: SRAX). The contract will facilitate media buys and digital…

Continue Reading

ThursdayJan 13, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Targeting Increased Revenue and Margins with Strategic Focus on Vertical Integration

RWB recently reported its Q3 2021 financial results in which revenues grew 93% YOY The company is pursuing vertical integration in multiple states, including Florida, California, and Michigan In Florida, RWB has launched cultivation operations and a processing facility expected to provide additional inventory for its Springhill dispensary, as well as three new dispensaries set to be opened in Q1 2022 According to RWB Chairman and CEO Brad Rogers, vertical integration will help drive increased revenue and margins for the company In the third quarter of fiscal 2021, multistate cannabis operator and house of premium brands Red White & Bloom…

Continue Reading

WednesdayJan 12, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Distribution Deal Increases CBD Product Reach to Mexico, Latin America

Plant-based wellness and lifestyle brand cultivator Flora Growth Corp. is building on its initial revenues from 2021 with distribution expansion into Mexico  The company will initially distribute a portfolio of 12 Mind Naturals skincare products through e-commerce but intends to eventually locate its products in brick-and-mortar stores The company’s deal with Mexican department store Coppel gives it a reach nationwide through its online marketplace and, perhaps eventually, Coppel’s 1,253 stores Flora Growth’s products will also be distributed through global retail giant Walmart’s e-commerce platform — one of the leading retail chains in Central America The company also has an outdoor…

Continue Reading

WednesdayJan 12, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Celebrates Productive Year for Blood Pressure Drug Solution with Eye on Advancing Clinical Studies in 2022

Lexaria Bioscience’s ongoing human clinical studies for its patented and trademarked DehydraTECH technology have yielded progressively optimistic results in 2021 regarding DehydraTECH’s ability to provide effective solutions for the cardiovascular industry DehydraTECH is being studied for its capacity to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic CBD formulation DehydraTECH-CBD underwent three human clinical studies in 2021 that examined its ability to reduce arterial stiffness and blood pressure without creating unintended negative consequences A fourth, more comprehensive study was approved at year’s end, as the next step…

Continue Reading

TuesdayJan 11, 2022 10:31 am

Q3 Report Notes Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Revenue Growth of 93 percent YOY

Red White & Bloom Brands is a cannabis multi-state operator building on opportunities in Michigan, Florida, Illinois, California, Arizona, Oklahoma and Massachusetts to create a synergistic portfolio throughout North America RWB is also building its hemp-based CBD products retail throughout the United States and into international markets The company has released its third quarter financial report on revenue growth, operational development and progress in finalizing additional agreements The report notes revenues grew from $6.1 million to $11.8 million year-over-year, largely as the result of its acquisition of its premium Platinum Vape  The company anticipated having 30 grow pods in place…

Continue Reading

MondayJan 10, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Independent Review Board Approval for Its Most Ambitious, Comprehensive Human Study Yet

Lexaria has received approval from the Independent Review Board for its DehydraTECH-CBD Human Clinical HYPER-H21-4 study The approval signals the company has taken the appropriate steps to protect the rights and welfare of human subjects participating in its fourth human study HYPER-H21-4 should "de-risk" outcomes prior to Lexaria's planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease Previous studies – HYPER-H21-1 and HYPER-H21-2 – have evidenced a remarkable, rapid, and safe drop in blood pressure with DehydraTECH-CBD A little less than two months after Lexaria Bioscience (NASDAQ: LEXX) announced…

Continue Reading

FridayJan 07, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC), a 2021 Year Review

2021 marked the year when Flora Growth held its IPO - the company’s common shares commenced trading on the Nasdaq Capital Market in May under the ticker symbol “FLGC" It also marked the year when the company ventured into the European market, as well as other key regions such as Mexico Significant acquisitions for the 2021 calendar year included Koch & Gsell, Vessel Brand Inc., and GMP-Certified Laboratory Flora Growth also made notable appointments to its executive leadership as well as its board of directors Flora Growth (NASDAQ: FLGC) had an impressive year in 2021, highlighted by the company’s Initial…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977